AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.460
-0.080 (-3.15%)
At close: Sep 17, 2025, 4:00 PM EDT
2.490
+0.030 (1.22%)
After-hours: Sep 17, 2025, 7:04 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $243.40 million as of September 17, 2025. Its market cap has decreased by -24.29% in one year.
Market Cap
243.40M
Enterprise Value
89.72M
1-Year Change
-24.29%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $243.40M, a decrease of -71.94%. That is a compound annual growth rate of -13.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 255.00M | -5.42% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.21B |
| Johnson & Johnson | 426.32B |
| AbbVie | 386.79B |
| UnitedHealth Group | 308.21B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |